| CTRI Number |
CTRI/2024/12/078190 [Registered on: 16/12/2024] Trial Registered Prospectively |
| Last Modified On: |
11/12/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Role of homoeopathic medicine in cerebral palsy in children. |
|
Scientific Title of Study
|
Assessing The Effectiveness of LM Potency in the Management of Spastic Cerebral Palsy in Children: A Pre & Post Intervention Clinical Study. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Rahul Kumar Chauhan |
| Designation |
PG Scholar |
| Affiliation |
Bakson Homoeopathic Medical College |
| Address |
Department of Practice of Medicine
Basement floor
Room No 16
Bakson Homoeopathic Medical college & hospital B 36 Knowledge park I Greater Noida
Gautam Buddha Nagar UTTAR PRADESH 201310 India |
| Phone |
8518807604 |
| Fax |
|
| Email |
rahulmedi91@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Man Mohan Chamoli |
| Designation |
Guide & Assistant Professor |
| Affiliation |
Bakson Homoeopathic Medical College |
| Address |
Department of Practice of Medicine
Basement floor
Room No 16
Bakson Homoeopathic Medical college & hospital B 36 Knowledge park I Greater Noida
Gautam Buddha Nagar UTTAR PRADESH 201310 India |
| Phone |
7838034913 |
| Fax |
|
| Email |
manu0001sm@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Akshay Mathur |
| Designation |
HOD & Professor |
| Affiliation |
Bakson Homoeopathic Medical College |
| Address |
Department of Practice of Medicine
Basement floor
Room No 16
Bakson Homoeopathic Medical college & hospital B 36 Knowledge park I Greater Noida
Gautam Buddha Nagar UTTAR PRADESH 201310 India |
| Phone |
9868121727 |
| Fax |
|
| Email |
drakshaymathur@gmail.com |
|
|
Source of Monetary or Material Support
|
| Bakson Homoeopathic Medical College and Hospital
36 B Knowledge park 1 Greater Noida Goutam Buddha Nagar UP India pin code 201310 |
|
|
Primary Sponsor
|
| Name |
Bakson Homoeopathic Medical College and Hospital |
| Address |
Principal Office
Bakson Homoeopathic Medical College And Hospital and hospital
Ground floor room no G22
B 36 Knowledge park 1 Greater Noida Goutam Buddha Nagar UP India pin code 201310 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Rahul Kumar Chauhan |
Bakson Homoeopathic Medical College and hospital |
out patient department (OPD) bakson homoeopathic medical college and hospital ground floor room no 1 B 36 knowledge park 1 Gautam Buddha Nagar UTTAR PRADESH |
8518807604
rahulmedi91@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Bakson Institutional Ethical commitee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: G800||Spastic quadriplegic cerebral palsy, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Homoeopathic in LM Potency |
Oral Route Of Administration liquid form (water as vehicle), one poppy size globule of desired potency will be dissolved in 120 ml of distilled water, 1 teaspoon is added in a cup of water is to be considered as 1st dose given after case taking repetion is based on susceptibility and follow up of the patient at regular interval of 1 month |
| Comparator Agent |
not applicable |
not applicable |
|
|
Inclusion Criteria
|
| Age From |
4.00 Year(s) |
| Age To |
12.00 Year(s) |
| Gender |
Both |
| Details |
Children from both sexes up to the age group of 04 to 12 years
Mild to moderate spastic CP with speech and social developmental delay
Participants/ guardian who are willing to give assent/consent for the study
|
|
| ExclusionCriteria |
| Details |
Exclusion criteria on severe physical disabilities, genetic disorders like Down syndrome, convulsion and sensory disorders like blindness and deafness
Children suffering simultaneously from other chronic infections (eg MDR tuberculosis or HIV disease)
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
Changes will be observed in MAS GMFM and CPQOL.
Changes can be positive or negative or no change. |
15 months
Enrollments-6 months
Follow up- 6 months
Statistical analysis- 3 months
First dose will be given after case taking.
subsequent doses as per the follow ups.
MAS, GMFM and CPQOL will be used at baseline 3 months and 6 months. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| N/A |
N/A |
|
|
Target Sample Size
|
Total Sample Size="33" Sample Size from India="33"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
27/12/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This is a single blind clinical study by using the indivisualized homoeopathic treatment in LM potency in the management of spastic cerebral palsy. the primary outcome is to assess the change in MAS, GMFM, and CPQOL scale at baseline 3rd month and 6th months and the result will be concluded accordingly. |